Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11104701 Neuroactive steroids and methods of use thereof

Patent 11104701 was granted and assigned to SAGE Therapeutics on August, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11104701

Patent Inventor Names

Francesco G. Salituro0

Albert Jean Robichaud0

Boyd L. Harrison0

Gabriel Martinez Botella0

Date of Patent

August 31, 2021

Patent Application Number

20181220

Date Filed

December 20, 2018

Patent Citations Received

‌

US Patent 11407782 Oxysterols and methods of use thereof

‌

US Patent 11878995 Oxysterols and methods of use thereof

‌

US Patent 11851457 Oxysterols and methods of use thereof

‌

US Patent 11884697 Oxysterols and methods of use thereof

‌

US Patent 11905309 Neuroactive steroids and methods of use thereof

‌

US Patent 11926646 C7 substituted oxysterols and methods of use thereof

‌

US Patent 12129276 Oxysterols and methods of use thereof

‌

US Patent 12129275 Neuroactive steroids, compositions, and uses thereof

Patent abstract

Compounds are provided according to Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11104701 Neuroactive steroids and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API